Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-02-08 @ 12:31 AM
Study NCT ID:
NCT01990534
Status:
COMPLETED
Last Update Posted:
2021-04-09
First Post:
2013-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Sponsor:
Organization: